Cargando…

2453. Wastewater-Based Surveillance of Vancomycin-Resistant Enterococci in Hospitals

BACKGROUND: Vancomycin-resistant Enterococcus (VRE) is an important nosocomial infection that may increase patient morbidity, mortality, and healthcare costs. We have adapted wastewater-based surveillance (WBS) as a novel tool to comprehensively and inclusively monitor the burden of VRE in tertiary...

Descripción completa

Detalles Bibliográficos
Autores principales: Au, Emily, Acosta, Nicole, Waddell, Barbara, Du, Kristine, Bautista, Maria, McCalder, Janine, Van Doorn, Jennifer, Low, Kashtin, Clark, Rhonda, Pitout, Johann, Leal, Jenine, Missaghi, Bayan, Kanji, Jamil, Larios, Oscar, Rennert-May, Elissa, Kim, Joseph, Lee, Bonita, Pang, Xiao-Li, Frankowski, Kevin, Hubert, Casey R J, Conly, John, Parkins, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678398/
http://dx.doi.org/10.1093/ofid/ofad500.2071
Descripción
Sumario:BACKGROUND: Vancomycin-resistant Enterococcus (VRE) is an important nosocomial infection that may increase patient morbidity, mortality, and healthcare costs. We have adapted wastewater-based surveillance (WBS) as a novel tool to comprehensively and inclusively monitor the burden of VRE in tertiary acute care hospitals. Herein, we demonstrate our ability to detect, quantify and track VRE dynamically over time across a range of scales. METHODS: Wastewater (WW) was collected from three hospitals in Calgary, AB: Rockyview General Hospital (RGH; 615 beds), Peter Lougheed Centre (PLC; 517 beds), and Foothills Medical Centre (FMC via three independent sites – A, B, C; 1100 beds). Three WW treatment plants (WWTPs; BBW, PCW, and FCW) serving the entire City of Calgary were sampled as community controls. DNA was extracted from WW pellets obtained following centrifugation. A multiplexed qPCR assay was adapted and used to quantify the abundances of the vanA and vanB resistance gene copies. Copy numbers were assessed as raw (copies per mL of WW processed) or normalized against three fecal biomarker genes: total bacterial 16S rRNA, human 18S rRNA, and Bacteroides HF183 16S rRNA. Differences between hospitals and controls were determined with Mann-Whitney tests (GraphPad Prism version 9.0). RESULTS: Samples from the hospitals and WWTPs in Calgary, AB collected over 12 weeks demonstrated that all hospitals had 100-1000X higher mean aggregate abundances of both vanA and vanB relative to community-based WWTPs when assessed as raw or normalized by each fecal biomarker (Figure 1; only total bacterial 16S rRNA is shown, p< 0.001, Mann-Whitney). Within one individual hospital (RGH), each of vanA and vanB abundances follows similar trends over a 12-week period, regardless of whether the values were reported as raw or normalized with the three different fecal biomarker genes (Figure 2; only vanA is shown). [Figure: see text] [Figure: see text] CONCLUSION: WBS is a unique real-time tool that can be adapted to monitor the abundance of VRE across a range of scales. This tool has the potential to augment antimicrobial stewardship and infection prevention and control programs to better understand the contributing factors to selection and colonization. DISCLOSURES: All Authors: No reported disclosures